Results 81 to 90 of about 49,855 (183)

LTBP3 Frameshift Variant in British Shorthair Cats with Complex Skeletal Dysplasia. [PDF]

open access: yesGenes (Basel), 2021
Rudd Garces G   +7 more
europepmc   +1 more source

Multi-campaign ship and aircraft observations of marine cloud condensation nuclei and droplet concentrations. [PDF]

open access: yesSci Data, 2023
Sanchez KJ   +38 more
europepmc   +1 more source

Vagueness, credibility, and government policy [PDF]

open access: yes
A discussion of the reasons why it may be in a government agency's--and society's--best interest to be vague about policy objectives. Using the concept of "cheap talk," the author explains that when an agency faces a trade-off between precise and ...
Joseph G. Haubrich
core  

SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN). [PDF]

open access: yesLancet, 2021
Hall VJ   +23 more
europepmc   +1 more source

Temma Berg, Professor of English

open access: yes, 2018
In this first Next Page column of 2018, Temma Berg, Professor of English, shares which texts have had a lasting influence on her teaching career and scholarship, how a chance meeting created a connection between her and one of her favorite childhood ...
Berg, Temma F., Musselman Library,
core  

Pregnancy and neonatal outcomes of COVID-19: coreporting of common outcomes from PAN-COVID and AAP-SONPM registries. [PDF]

open access: yesUltrasound Obstet Gynecol, 2021
Mullins E   +10 more
europepmc   +1 more source

Substance use stigma: A systematic review of measures and their psychometric properties. [PDF]

open access: yesDrug Alcohol Depend Rep
Spata A   +4 more
europepmc   +1 more source

Challenges and opportunities for conducting a vaccine trial during the COVID-19 pandemic in the United Kingdom. [PDF]

open access: yesClin Trials, 2021
Török ME   +23 more
europepmc   +1 more source

Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study. [PDF]

open access: yesLancet Gastroenterol Hepatol, 2023
Liu Z   +22 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy